News
Confidential report reveals: Big Pharma trying to stop long-term safety studies of ADHD drugs (Ritalin, Concerta)
A confidential document, now made public by a Swedish court, tells how pharmaceutical companies (calling themselves the “Consortium”) are trying to stop long-term safety studies of ADHD drugs (Ritalin, Concerta)
The companies producing methylphenidate products (like Ritalin and Concerta) are normally competitors, marketing ADHD as a disease and the narcotic drugs as its solution. But when they are threatened with marketing restrictions they have a common interest.
If more scientific long-term studies would be done showing the harmful effects of the drugs it could lead to withdrawal from the market of this class of drugs. Therefore Big Pharma has to stop all such studies not written and controlled by themselves. The only studies they support are those conducted by paid researchers like psychiatry professors Joseph Biederman, Timothy Wilens and Thomas Spencer, where the outcome is known already from the beginning.
The European Commission has
So for example the manufacturers were ordered to submit data how they could do long-term studies of psychiatric adverse effects (e.g. depression, hostility and psychotic reactions) and of cognitive effects (effects on learning, intellectual function) of the drugs. The answer from the pharmaceutical companies was a confidential report Feasibility Assessment of a Study of Long-term Effects of Methylphenidate on Cognition and Psychiatric Outcomes written
As stated by the manufacturers: “This information is provided on behalf of the following Marketing Authorisation Holders for methylphenidate-containing medicinal products in the EU: Novartis, Johnson & Johnson, Shire, Medice and Laboratorios Rubió (also referred to as the “Consortium”).”
The document can only be characterised as an aggressive effort to explain why long-term studies about adverse psychiatric outcomes of methylphenidate treatment could not and should not be done, together with distorted facts about the beneficial long-term outcomes of drug treatment. The intention with the feasibility assessment study is clearly to stop or delay needed safety actions for methylphenidate drugs.
The main method used by the Consortium to prevent the safety studies is the “comorbidity trick”. This means that any and all adverse reactions from the drugs are explained away as signs of a “co-occuring disease”. As the Consortium says: “It is well established that ADHD co-occurs with other psychiatric disorders.” The list that follows is long: “disruptive behavioral disorders such as oppositional defiant disorder, conduct disorder; and mood disorders such as depression, bipolar disorder; and anxiety disorders.”
Many references are made to Dr. Joseph Biederman – the father of the disastrous invention pediatric bipolar disorder, and subject to Congressional investigations in the
With this the Consortium wants to say that when a child on methylphenidate exhibits agitation or mania it should directly be seen as the “co-occuring disease” bipolar disorder popping up. Meaning in turn that they now have something more for which psychiatric drugs needs to be prescribed. This time heavy antipsychotic drugs, like Risperdal, Invega, Clozaril, Seroquel and Zyprexa.
The CAUSAL role for methylphenidate products in inducing psychotic reactions, mania, aggression and hostility has been proven in many studies. The long 2006 report from FDA about this subject, told very much (FDA, Psychiatric Adverse Events Associated with Drug Treatment of ADHD: Review of Postmarketing Safety Data,
It has taken many years to get the warnings out about these harmful effects. Many children have been considered psychotic and put on antipsychotic drugs – with even more harm produced – when the actual fact was that they experienced toxic effects from methylphenidate drugs. Many children have experienced new or exacerbated aggressiveness as a result of taking stimulant drugs, which in turn have put them and people around them in danger.
But the pharmaceutical companies do not even accept these since long proven harmful effects. In the conclusions section of the report they say: “[data] do not indicate any signal of worsening of psychiatric symptoms or cognition during treatment with MPH [methylphenidate] and even suggest a beneficial long-term effect of MPH on the course of psychiatric disorders and cognitive function over time.”
So now it’s up to the European authorities to choose: Should they accept the aggressive effort by Big Pharma to prevent the safety studies or should they prevent continued harm on children?
See the now released report from the Consortium: Feasibility Assessment of a Study of Long-term Effects of Methylphenidate on Cognition and Psychiatric Outcomes http://jannel.se/Consortium_ADHD-drugs.pdf
Janne Larsson
Reporter – investigating psychiatry
More News
Young Women, Antidepressants and Suicide A report on the situation in Sweden 2013
We have read in the media that “psychiatric disorders” and the number of suicides are increasing among young women. This increase is in Sweden parallel with a heavy increase in the prescription of antidepressants and other psychiatric drugs to yo ...
Released On: 12/9/2014
Views: 5137
Research fraud, prisoners and ADHD drugs in Sweden
The study was hailed in media and used for new prescription guidelines. But the actual disastrous results were concealed. No one – except the researchers involved – knew that 26% of the subjects receiving the “ADHD drug”
Released On: 11/11/2014
Views: 8490
ADHD drug Concerta disapproved for adults in Europe
The European medical agencies have disapproved the ADHD drug Concerta for adults. The well selected short-term clinical trials did not hold: No certain positive effects; clear evidence that Concerta can cause anxiety and agitated conditions in ad ...
Released On: 10/7/2011
Views: 15536
ADHD: Strattera Death Count Continued – 137 Reports of Deaths, 57 were Children
Released On: 11/7/2010
Views: 7647
Renowned Psychiatry Professor Helped Forest Labs Cover up Bad Results of Antidepressant in Children
Released On: 3/30/2010
Views: 4131
Confidential report reveals: Big Pharma trying to stop long-term safety studies of ADHD drugs (Ritalin, Concerta)
Released On: 3/5/2010
Views: 11684
Official warnings issued: The ADHD drug Strattera CAUSES psychosis, hallucinations, mania and agitation
Released On: 12/2/2008
Views: 17602
New data shows antidepressants and neuroleptics involved in 77 percent of reported suicides
Released On: 8/8/2008
Views: 4164
New study about antidepressants – Big Pharma and medical agency working close together to save profits and careers
Released On: 6/26/2008
Views: 5421
The ADHD drug Strattera: Lilly to issue warnings about psychosis, hallucinations, mania and agitation
Released On: 4/28/2008
Views: 3379
National data: Psychiatric drugs behind 75 percent of all female suicides
Newly uncovered data show that psychiatric drugs were behind 75 percent of ALL suicides among women (18-84) in Sweden (2006); antidepressants were behind 52 percent.
Released On: 2/7/2008
Views: 4481
Antidepressants behind 52 percent of all suicides among women
Released On: 1/22/2008
Views: 15810
Reported suicides – more than 80 percent got psychiatric drugs, well over 50 percent got antidepressants
Released On: 10/7/2007
Views: 10771
The endocrine effects of the psychiatric drug Zyprexa are extremely dangerous, says Swedish Professor in Psychiatry
Released On: 9/13/2007
Views: 5221
Map
larsson telia.com
Get Directionslarsson telia.com
-
Snöbollsgränd 22
Hägersten, Stockholm 12945
Sweden - 0094687089342
